Overview

A Study Evaluating Maintenance Therapy After First Line Chemotherapy in Metastatic Cancer Pancreas

Status:
Recruiting
Trial end date:
2024-09-11
Target enrollment:
Participant gender:
Summary
A randomized phase II study evaluating maintenance therapy after first line induction chemotherapy in metastatic cancer pancreas.
Phase:
Phase 2
Details
Lead Sponsor:
Menoufia University
Treatments:
Capecitabine